List of works - Jin Wang

20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo

scientific article published on 7 January 2013

Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength

scientific article published on 21 April 2012

Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties

scientific article

Design, synthesis, and biological action of 20R-hydroxyvitamin D3.

scientific article published on 20 March 2012

Design, synthesis, and biological evaluation of stable colchicine binding site tubulin inhibitors as potential anticancer agents

scientific article

Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative properties

scientific article published on 9 April 2013

Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents

scientific article

Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors

scientific article

In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland.

scientific article published on 29 December 2013

New substituted 4H-chromenes as anticancer agents

scientific article published on 24 April 2012

Novel activities of CYP11A1 and their potential physiological significance.

scientific article published on 13 November 2014

Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melanoma lung metastasis

scientific article published on 13 March 2012

RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D.

scientific article

Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents

scientific article

Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma.

scientific article

Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization

scientific article

List of works by Jin Wang

20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo

Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength

Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties

Design, synthesis, and biological action of 20R-hydroxyvitamin D3.

Design, synthesis, and biological evaluation of stable colchicine binding site tubulin inhibitors as potential anticancer agents

Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative properties

Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents

Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors

In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland.

New substituted 4H-chromenes as anticancer agents

Novel activities of CYP11A1 and their potential physiological significance.

Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melanoma lung metastasis

RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D.

Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents

Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma.

Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization